High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors.
Alv A DahlSolveig K SmedslandKathrine F VandraasSynne K BøhnRagnhild S FalkCecilie E KiserudKristin V ReinertsenPublished in: Breast cancer research and treatment (2023)
High neuroticism is prevalent and associated with increased risks of LAEs among BCSs. Identification of high neuroticism could improve the follow-up care of BCSs as effective interventions for the condition exist.